These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 16941956

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The inhibitory effect of tannic acid on cytochrome P450 enzymes and NADPH-CYP reductase in rat and human liver microsomes.
    Yao HT, Chang YW, Lan SJ, Yeh TK.
    Food Chem Toxicol; 2008 Feb; 46(2):645-53. PubMed ID: 17950511
    [Abstract] [Full Text] [Related]

  • 3. Differential selectivity of cytochrome P450 inhibitors against probe substrates in human and rat liver microsomes.
    Eagling VA, Tjia JF, Back DJ.
    Br J Clin Pharmacol; 1998 Feb; 45(2):107-14. PubMed ID: 9491822
    [Abstract] [Full Text] [Related]

  • 4. In vitro comparison of cytochrome P450-mediated metabolic activities in human, dog, cat, and horse.
    Chauret N, Gauthier A, Martin J, Nicoll-Griffith DA.
    Drug Metab Dispos; 1997 Oct; 25(10):1130-6. PubMed ID: 9321515
    [Abstract] [Full Text] [Related]

  • 5. In vitro metabolism of fipronil by human and rat cytochrome P450 and its interactions with testosterone and diazepam.
    Tang J, Amin Usmani K, Hodgson E, Rose RL.
    Chem Biol Interact; 2004 Apr 15; 147(3):319-29. PubMed ID: 15135087
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of common organic solvents on in vitro cytochrome P450-mediated metabolic activities in human liver microsomes.
    Chauret N, Gauthier A, Nicoll-Griffith DA.
    Drug Metab Dispos; 1998 Jan 15; 26(1):1-4. PubMed ID: 9443844
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the selectivity of In vitro probes and suitability of organic solvents for the measurement of human cytochrome P450 monooxygenase activities.
    Hickman D, Wang JP, Wang Y, Unadkat JD.
    Drug Metab Dispos; 1998 Mar 15; 26(3):207-15. PubMed ID: 9492382
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Characterization of the cytochrome P450 enzymes involved in the metabolism of a new cardioprotective agent KR-33028.
    Kim H, Yoon YJ, Kim H, Kang S, Cheon HG, Yoo SE, Shin JG, Liu KH.
    Toxicol Lett; 2006 Oct 10; 166(2):105-14. PubMed ID: 16857327
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effects of flavonoids isolated from Scutellariae radix on cytochrome P-450 activities in human liver microsomes.
    Kim JY, Lee S, Kim DH, Kim BR, Park R, Lee BM.
    J Toxicol Environ Health A; 2002 Mar 10; 65(5-6):373-81. PubMed ID: 11936218
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The antibiotic tiamulin is a potent inducer and inhibitor of cytochrome P4503A via the formation of a stable metabolic intermediate complex. Studies in primary hepatocyte cultures and liver microsomes of the pig.
    Witkamp RF, Nijmeijer SM, Monshouwer M, Van Miert AS.
    Drug Metab Dispos; 1995 May 10; 23(5):542-7. PubMed ID: 7587928
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of human liver cytochrome P450 enzymes involved in the metabolism of a new H+/K+-ATPase inhibitor KR-60436.
    Ji HY, Lee HW, Kim HH, Choi JK, Lee HS.
    Toxicol Lett; 2005 Jan 15; 155(1):103-14. PubMed ID: 15585365
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.